| Authors: |
Iannone M; Johnson&Johnson, Neuroscience Discovery, Beerse, Belgium.; Philip Morris R&D, Quai Jeanrenaud 5, 2000, Neuchatel, Switzerland., Loomans T; Johnson&Johnson, Preclinical Sciences & Translational Safety, Beerse, Belgium., Gorremans S; Johnson&Johnson, Neuroscience Discovery, Beerse, Belgium., Grajchen E; Johnson&Johnson, Neuroscience Discovery, Beerse, Belgium., Deneubourg C; Johnson&Johnson, Neuroscience Discovery, Beerse, Belgium., Hrupka B; Johnson&Johnson, Neuroscience Discovery, Beerse, Belgium., Ver Donck L; Johnson&Johnson, Neuroscience Discovery, Beerse, Belgium., Bretteville A; Johnson&Johnson, Neuroscience Discovery, Beerse, Belgium., Moechars D; Johnson&Johnson, Neuroscience Discovery, Beerse, Belgium., Vreeken RJ; Johnson&Johnson, Preclinical Sciences & Translational Safety, Beerse, Belgium.; Maastricht MultiModal Molecular Imaging Institute (M4I), Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, The Netherlands.; TNO, Health & Work, Sylviusweg 71, 2333 BE, Leiden, the Netherlands., Jahouh F; Johnson&Johnson, Preclinical Sciences & Translational Safety, Beerse, Belgium. fjahouh@its.jnj.com. |
